Inify Laboratories saw important pieces fall into place during the fourth quarter of 2023, the foremost being the attainment of accreditation as a medical laboratory. This paved the way for making Inify’s diagnostic service fully available to both private and public healthcare providers resulting in considerable sales growth.
This and other highlights of the quarter are discussed in a panel talk led by Ole Eikeland, where Inify’s CEO Fredrik Palm and Sales & Marketing Manager Maria Holmberg share their thoughts both on the past months and the future. Link to the panel talk is available here.
For more information, contact CEO Fredrik Palm, , or visit https://www.inify.com.